It serves as a core scaffold for developing antiviral and anticancer nucleoside analogs. The deaza modification improves chemical stability and enables selective functionalization during drug synthesis. 7-Deazahypoxanthine is a deazapurine derivative used as a key intermediate in the synthesis of purine-based active pharmaceutical ingredients (APIs).
7-Deazahypoxanthine
| API Name | Tofacitinib |
|---|---|
| CAS No | 3680-71-5 |
| Molecular Formula | C6H5N3O |
| Molecular Weight | 135.12 g/mol |
| Synonyms | 3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It serves as a core scaffold for developing antiviral and anticancer nucleoside analogs. The deaza modification improves chemical stability and enables selective functionalization during drug synthesis. 7-Deazahypoxanthine is a deazapurine derivative used as a key intermediate in the synthesis of purine-based active pharmaceutical ingredients (APIs).
The CAS number of 7-Deazahypoxanthine is 3680-71-5.
The molecular formula of 7-Deazahypoxanthine is C6H5N3O.
The listed molecular weight of 7-Deazahypoxanthine is 135.12 g/mol.
7-Deazahypoxanthine is listed as being used in connection with the following API: Tofacitinib.
The listed synonym or IUPAC name for 7-Deazahypoxanthine is 3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one.